Material Transfer Conditions note
You need MTA with Michigan Univ.
Joint research
If you use GAD67(Gad1)-Cre mouse, please contact Prof. Kenji Sakimura for MTA.
The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. RECIPIENT which wants to use the BIOLOGICAL RESOURCE for the purpose other than education or not-for-profit research is requested to enter into a Material Transfer Agreement with Osaka University. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. The RECIPIENT which wants to use the BIOLOGICAL RESOURCE even after five years must obtain a written consent from the DEPOSITOR again.
The RECIPIENT must contact the person listed below in the case of application for any patents or commercial use based on the results from the BIOLOGICAL RESOURCES. mta-egr@biken.osaka-u.ac.jp (Contact to Masahito Ikawa)
mta-egr@biken.osaka-u.ac.jp (Contact to Masato Ikawa)
(1) Recipient and Recipient scientist shall receive the prior written approval from Provider, if Recipient scientist uses the material with anyone else outside of the Recipient scientist's laboratory to carry out the Research. (2) The material shall be used only by Recipient scientist and others working under Recipient scientist's direct supervision at Recipient scientist's laboratory, and shall not be used by, as well as shall not be distributed and assigned to anyone else either at the Recipient organization or outside the organization. (3) At the time of publication of the result from the Research using the material, whether in print or in electronic form, Recipient scientist shall provide a copy of each publication to Provider. (4) Recipient and Recipient scientist acknowledge that this Agreement is not the agreement to license the intellectual property rights relating the material owned by Provider to Recipient and Recipient scientist. Recipient and Recipient scientist also acknowledge that no express or implied licenses or other rights are provided to Recipient and Recipient scientist from Provider to use the material, or any related patents of Provider for commercial purposes. (5) Recipient scientist shall cite the paper specified below in any publication of the result from the Research. Murakami, M. et al. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol. 2004 Aug;24(15):6710-8.
If you use Gsh2-Flpe mouse, please contact Dr. Tsutomu Hirata for MTA.
The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the BIOLOGICAL RESOURCES .
Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE.
In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.
If you use Nkx2.1(Nkx2-1)-iCre mouse, please contact Dr.Kesarris Nicoletta for MTA.
If you use Gsh2-iCre mouse, please contact Dr.Kesarris Nicoletta for MTA.
Collaboration permission is required for usage of this line
mta-egr@biken.osaka-u.ac.jp (Contact to Masahito Ikawa)
The RECIPIENT must contact the person listed below in the case of application for any patents or commercial use based on the results from the BIOLOGICAL RESOURCES. mta-egr@biken.osaka-u.ac.jp (Contact to Masahito Ikawa)
If you use Fezf1 knockout mouse, please contact Dr. Tsutomu Hirata for MTA.
If you use Pax6-CreER mouse, please contact Dr. Tsutomu Hirata for MTA.
RECIPIENT agrees to include Drs. Shin-ichi Abe (kumamoto University) and Choji Taya (Tokyo Metropolitan Institute of Medical Science) as co-authors in the first major publication with the use of the MATERIAL and to send the draft manuscript to both of them before submission.
(1) Recipient and Recipient scientist shall receive the prior written approval from Provider, if Recipient scientist uses the material with anyone else outside of the Recipient scientist's laboratory to carry out the Research. (2) The material shall be used only by Recipient scientist and others working under Recipient scientist's direct supervision at Recipient scientist's laboratory, and shall not be used by, as well as shall not be distributed and assigned to anyone else either at the Recipient organization or outside the organization. (3) At the time of publication of the result from the Research using the material, whether in print or in electronic form, Recipient scientist shall provide a copy of each publication to Provider. (4) Recipient and Recipient scientist acknowledge that this Agreement is not the agreement to license the intellectual property rights relating the material owned by Provider to Recipient and Recipient scientist. Recipient and Recipient scientist also acknowledge that no express or implied licenses or other rights are provided to Recipient and Recipient scientist from Provider to use the material, or any related patents of Provider for commercial purposes. (5) Recipient scientist shall cite the paper specified below in any publication of the result from the Research. Murakami, M. et al. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol. 2004 Aug;24(15):6710-8.
institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE.
Request not to be distributed until publication.Please notify when the request is made.
If you use NEX(Neurod6)-Cre mouse, please contact to Prof. Klaus-Armin Nave in Max Planck Institute for MTA.
It is necessary to quote the following article.
Inoue S, Inoue M, Fujimura S, and Nishinakamura R. A mouse line expressing Sall1-driven inducible Cre recombinase in the kidney mesenchyme. Genesis 48: 207-212, 2010.GIE-CERBM (IGBMC) has designed the Cre-ERT2 construct and has been granted an US patent (No7112715) and an European patent (NoIB01/02246) that cover the use of Cre-ERT2 transgenic mice. Kumamoto University may transfer MATERIAL, MODIFICATIONS, and/or derived Cre-ERT2-containing transgenic mice to other scientists at non-profit institutions ("Collaborator") for non-industrially sponsored research, non-commercial, internal, and academic research if, and only if, Collaborator has obtained a Cre-ERT2 MTA from IGBMC (please contact chambon@igbmc.fr to obtain a copy of the MTA).
The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the BIOLOGICAL RESOURCES.
In publishing the research results obtained by use of the CARD, a citation of the literature designated by the DEPOSITOR is requested.
1;In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested (will be announced). 2;Within a period of 3 years after deposition of the material, user must contact bailor and notify him a content of the research. If the bailor judges that the research should be a collaborative work, then user must include bailor and/or developer's names as co-authors.
collaboration
Kazuya Yamagata 1-1-1 Honjo, Chuo-ku, Kumamoto Faculty of Life Sciences Kumamoto University
The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. RECIPIENT which wants to use the BIOLOGICAL RESOURCE for the purpose other than education or not-for-profit research is requested to enter into a Material Transfer Agreement with Osaka University. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. The RECIPIENT which wants to use the BIOLOGICAL RESOURCE even after five years must obtain a written consent from the DEPOSITOR again.
The RECIPIENT must contact the person listed below in the case of application for any patents or commercial use based on the results from the BIOLOGICAL RESOURCES mta-egr@biken.osaka-u.ac.jp (Contact to Masahito Ikawa)
If you use sFRP2-CreER mouse, please contact Dr. Tsutomu Hirata for MTA.
You must cite the following paper. Tamakoshi T, Itakura T, Chandra A, Uezato T, Yang Z, Xue X-D, Wang B, Hackett BP, Yokoyama T, Miura N: Roles of the Foxj1 and Inv genes in the left-right determination of internal organs in mice. Biochem Biophys. Res Commun 339: 932-938, 2006.
If you use Dbx1-CreER mouse, please contact Dr. Tsutomu Hirata and Dr.Joshua Corbin for MTA.
RECIPIENT agrees to include Drs. Shin-ichi Abe (Kumamoto University) and Choji Taya (Tokyo Metropolitan Institute of Medical Science) as co-authors in the first major publication with the use of the MATERIAL and to send the draft manuscript to both of them before submission.
mta-egr@biken.osaka-u.ac.jp(Contact to Masato Ikawa)
The RECIPIENT must contact the person listed below in the case of application for any patents or commercial use based on the results from the BIOLOGICAL RESOURCES.
mta-egr@biken.osaka-u.ac.jp (Contact to Masahito Ikawa)
The RECIPIENT must the DEPOSITOR in the case of application for any patents or commercial use based on the results from the BIOLOGICAL RESOURCES.
Need acknowledgement in publishing paper.
If you use Fezf2 knockout mouse, please contact Dr. Tsutomu Hirata for MTA.
If you use SP8-CreER mouse, please contact Dr. Tsutomu Hirata for MTA.
The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. RECIPIENT which wants to use the BIOLOGICAL RESOURCE for the purpose other than education or not-for-profit research is requested to enter into a Material Transfer Agreement with Osaka University. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. The RECIPIENT which wants to use the BIOLOGICAL RESOURCE even after five years must obtain a written consent from the DEPOSITOR again.